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The expression of the human immunodeficiency virus type 1 mRNAs containing the Rev-responsive element is regulated
at the posttranscriptional level by the viral Rev protein. Rev increases the nucleocytoplasmic export of these mRNAs, leading
to high expression. Using in situ hybridization and electron microscopy, we investigated the localization of a subgenomic
gag mRNA in the absence and presence of Rev. In addition to the previously shown cytoplasmic accumulation of the Rev-
dependent mRNA, we observed that in the presence of Rev the nuclear gag mRNA accumulates nonrandomly and forms
specific localization patterns at the nuclear membrane and in the nucleoplasm. Cellular mRNAs for b-actin and glyceralde-
hyde-3-phosphate dehydrogenase were not found to form such patterns. These data suggest that Rev leads the gag mRNA
to specific subnuclear locations, which further supports the transport function of Rev. q 1997 Academic Press
The expression of human immunodeficiency virus type promoter, the p37gag gene followed by the HIV-1 3* LTR
providing the polyadenylation signal. The RNA produced1 (HIV-1) is controlled posttranscriptionally by the viral
from this vector does not contain known splice sites andRev protein. Rev binds to an RNA target, the Rev-respon-
does not undergo splicing (G. Nasioulas and B. K. Felber,sive element (RRE) (1 – 11) and increases the nucleocy-
unpublished observation). This plasmid produces verytoplasmic transport, stability, and translation of RRE-con-
low amounts of Gag protein due to the presence of insta-taining mRNAs (12 – 20). These pleiotropic effects are be-
bility/inhibitory elements located within the gag mRNAlieved to reflect a single unifying mechanism of Rev
(19, 29) and requires the Rev/RRE posttranscriptional reg-function. We and others proposed that Rev is an RNA
ulatory system for efficient expression. To analyze thechaperone that exports RRE-containing mRNAs from the
subcellular localization of the gag mRNA, we transfectednucleus to the cytoplasm, resulting in efficient expression
pB37R either alone or in the presence of a rev expression(13, 16, 21, 22). The detailed molecular mechanism by
plasmid into 10 plates. We quantitated Gag productionwhich Rev affects mRNA transport has not yet been eluci-
from 1 plate and processed the remaining 9 plates fordated. Several lines of evidence indicate that Rev shut-
electron microscopy and in situ hybridization. We foundtles between the nucleus and the cytoplasm, which sug-
that Rev increased the Gag protein accumulation aboutgests that Rev is involved in active mRNA transport (21,
70-fold, as expected (Fig. 1). To control for transfection23–28).
efficiencies, we included a luciferase expression plasmidUsing in situ hybridization and electron microscopy,
in the transfection mixtures. Measurements of luciferasewe studied the localization of a subgenomic mRNA ex-
activity in the cell lysates revealed equal transfectionpressing the HIV-1 p37gag gene in the absence and in
efficiencies (Fig. 1).the presence of posttranscriptional regulation by the viral
To visualize the gag mRNA in the transfected cells, weRev protein. HLtat cells were transiently transfected with
performed electron microscopy and in situ hybridizationpB37R (Fig. 1), a plasmid that contains the HIV-1 LTR
using cells from the same experiment as shown in Fig.
1. The gag mRNA in the absence (Fig. 2A) and presence
1 The U.S. Government’s right to retain a nonexclusive royalty-free (Fig. 2B) of Rev was detected by a digitonin-labeled probe
license in and to the copyright covering this paper, for governmental
that was visualized using rabbit anti-digitonin antibodypurposes, is acknowledged.
and gold particles conjugated to goat anti-rabbit IgG.2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 846-7146. E-mail: felber@ncifcrf.gov. Similar data were obtained using a biotin-labeled RNA
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cles/mm2; Table 1). These results are in agreement with
previously published data on biochemical and light mi-
croscopy/in situ hybridization analyses of the nuclear and
cytoplasmic localization of HIV-1 mRNA (13, 14, 16, 18).
In the nucleoplasm the concentration of gag mRNA was
marginally increased by Rev, whereas it was not affected
in the nucleolus (Table 1). This is expected since the
transcription of gag mRNA from the LTR promoter is not
affected by Rev. To verify the specificity of the hybridiza-
tion, we included as controls either nontransfected HLtat
cells or RNase A-treated transfected cells. In addition,
immunocytochemical controls were performed by either
omission of the anti-digitonin antibody (or anti-biotin anti-
body) or with normal rabbit IgG. Hybridization signals
were not detected in any of the controls (data not shown).
The most prominent effect of Rev was the localization
of gag mRNA in nonrandom patterns that fell into two
categories: short track-like structures immediately adja-
cent to or crossing the nuclear membrane (NM) (Fig. 3A)
and longer track-like structures in the nucleoplasm which
FIG. 1. Quantitation of Gag protein production. The HIV-1 gag expres- were often radially organized with respect to the nucleoli
sion plasmid pB37R contains the 5* long terminal repeat (LTR) promoter
and immediately contacted them (Fig. 4). In the absenceof HIV-1, the p37gag portion of the p55gag precursor consisting of the
of Rev, no significant labeling in the vicinity of the NMp17gag and p24gag genes followed by a terminator of translation, the 330-
nucleotide (nt) portion spanning the RRE (38) (providing three unique was observed, suggesting that the short patterns on the
restriction sites for BamHI, XbaI, and XhoI), and the HIV-1 3* LTR, NM are Rev-induced. In contrast, the nucleoplasmic la-
including the polyadenylation signal (39). pB37R produces an unspliced beling was only modestly increased by Rev (Table 1)
mRNA and depends on Rev for gag expression. HLtat cells, a HeLa
and, therefore, two subsequent statistical analyses werederivative that constitutively expresses HIV-1 Tat (40), were transfected
performed to check whether the longer nucleoplasmic(41, 42) with pB37R in the absence (0rev) and presence (/rev) of 1 mg
of the rev expression plasmid pLsrev (43). One day before transfection, patterns are nonrandom and Rev-induced.
logarithmically growing cells were trypsinized and seeded at 7 1 105 First, in order to evaluate the statistical significance of
cells per 60-mm plate and a total of 10 plates were used per transfec- nucleoplasmic grain patterns in Rev-containing cells, we
tion. To control for a uniform transfection efficiency, transfection mix-
performed computer-assisted cluster analysis of graintures included 1 mg of a luciferase expression plasmid pRSVluc (44).
distributions on five experimental photographs of Rev-At Day 3 posttransfection, cells from 9 plates were combined and
processed for electron microscopy (see below), while 1 plate was har- regulated gag mRNA over the nucleoplasm. In parallel,
vested for HIV-1 p24gag and luciferase measurements as described (38, for each experimental photograph, the same procedure
44). The p24gag measurements were performed using an antigen cap- was applied on 1000 random simulations of dot distribu-
ture assay kit (Cellular Products) according to the manufacturer’s in-
tion over the equivalent area. A cluster was defined asstructions. Black bars indicate Gag production in ng p24gag/ml (scale
a track-like pattern according to the following parame-to the right). Gray bars indicate the luciferase activity (light units) mea-
sured in the same lysates (scale to the left). ters: the number of dots (N 5), the diameter of a cluster
(D  D0 ; it should be long), and the ratio (D/N  D/N0 ;
it should be thin). The number of dots that belong to
probe. A total of three independent transfection experi-
ments were performed and the gold particles were quan-
TABLE 1titatively assessed in 20 cells for each parallel set of
plates in one experiment. In addition, about 100 cells Quantitation of Labeled HIV-1 gag mRNA in Different
Subcellular Compartmentseach were visually examined. Note that these cells were
transiently transfected with an efficiency of about 40%.
Minus Rev Plus Rev
We examined only cells showing average expression and
well-preserved morphology. Overexpressing cells that Compartment labeled (particles/mm2)
are occasionally obtained after transient transfection Entire cell 2.6 { 0.4 4.2 { 0.8
Cytoplasm 0.8 { 0.2 4.4 { 0.9may give an artifactual picture and were excluded from
Nucleoplasm 2.8 { 0.6 4.3 { 0.9the analysis. The gag mRNA concentration over the en-
Nucleolus 6.0 { 1.6 5.0 { 0.9
tire cell was only modestly increased by Rev (from 2.6 Frequency of nucleoplasmic tracksa 0.43 1.6
to 4.2 particles/mm2; Table 1), but the cytoplasmic con-
a Defined as an average number of nucleoplasmic tracks per cell.centration was increased by 5.5-fold (from 0.8 to 4.4 parti-
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FIGURE 2
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TABLE 2
Statistical Evaluation of Rev-Induced gag mRNA Tracks in the Nucleoplasm
Photograph No.
1 2 3 4 5 Mean
Minimal length of track (D0), nm 800 660 750 750 800 752
Z scorea for the number of
nucleoplasmic tracks per cell 4.26 3.18 5.73 3.73 5.74 4.53
Relative frequency of
nucleoplasmic tracksb 4.2 1.4 12 6 18.2 8.36
a Z score is the difference between the experimental number of tracks and the mean number of tracks of the statistical distribution for 1000
randomized pictures, expressed in units of standard deviation.
b Defined as a ratio of the experimental to the mean random number of tracks.
the above-defined patterns on experimental pictures was the localization of gag mRNA in the nucleoplasm is non-
random.counted. For each experimental photograph the mean
and standard deviation (SD) of the statistical distribution To further evaluate whether nonrandom patterns at the
nuclear membrane may be a general phenomenon ofof this number drawn from 1000 random pictures were
calculated and compared to the respective experimental any transported cellular mRNAs, we studied the localiza-
tion of endogenous mRNAs for b-actin and glyceralde-value. The parameter D0 varied slightly between pictures
and its average value (752 nm) was further used to manu- hyde-3-phosphate dehydrogenase (GAPDH), since both
have been widely used as examples of constitutively ex-ally count the tracks (see below). In experimental photo-
graphs we found a nonrandom occurrence (mean Z score pressed housekeeping genes. Their pre-mRNAs undergo
splicing and the mRNAs are subsequently exported to 4.53) of track-like structures containing more than 5
grains and of average length more than 752 nm. In experi- the cytoplasm in a manner that is likely to represent a
regular cellular mRNA pathway. To detect nuclearmental photographs, such patterns were on the average
eight times more frequent than on random distributions mRNAs that qualify for nucleocytoplasmic translocation,
we designed probes that span the exon junctions and(Table 2).
Second, the nucleoplasmic track-like patterns were therefore will preferentially detect spliced mRNAs. The
overall densities of specific RNA signals obtained for gagmanually counted on 20 representative photographs for
each transfection, using the parameters that emerged (Fig. 2), b-actin (Fig. 6), and GAPDH (data not shown)
mRNAs were comparable. Both actin and GAPDHfrom the first step, and their frequency was defined as
the average number of such patterns per cell. Under Rev mRNAs exhibited nuclear as well as cytoplasmic local-
ization, which further indicated that our technique is ade-regulation, these patterns were found four times more
frequently than in the absence of Rev (Table 1). Taken quate to detect potential intermediates of nuclear export.
However, we did not observe nonrandom patterns in thetogether, these data indicate that in the presence of Rev
FIG. 2. Localization of Rev-regulated gag mRNA by in situ hybridization and electron microscopy using a digitonin-labeled riboprobe. Parallel
plates of HLtat cells were transfected as described for Fig. 1 and were processed for the in situ hybridization and electron microscopy. Cells were
fixed in situ at 47 in 4% paraformaldehyde and 0.1% glutaraldehyde in phosphate-buffered saline (PBS) for 1 hr, scraped, pelleted, and embedded
in LR White (45). Ultrathin sections were prepared with an LKB Nova Ultrotome and collected on Formvar-Carbon-coated gold grids. The biotin-
labeled DNA probe was a double-stranded fragment spanning the gag gene (nt 711–2006) of HIV-1 molecular clone NL4-3 (46) (see Fig. 1). The
fragment was biotin-labeled using the FLASH Prime-It labeling kit (Stratagene) according to the manufacturer’s instructions. To prepare the digitonin-
labeled RNA probe, plasmid pDNC4 (E. Afonina and G. N. Pavlakis, unpublished) was cut with Asp718 and transcribed in vitro with T3 RNA
polymerase in the presence of digitonin RNA labeling mix (Boehringer). The resultant RNA spans nt 453–1210 of NL4-3 and is antisense to HIV-1
mRNA (see Fig. 1). To remove the residual transfected DNA, the sections were pretreated with DNase I (1 unit/ml; Worthington) for 1 hr at room
temperature in 10 mM Tris–HCl (pH 7.5), 5 mM MgCl2 , 1 mM dithiothreitol. The grids were floated over 2 ml of hybridization solution consisting of
50 ml of deionized formamide, 10 ml of 201 SSC buffer, 20 ml of 50% dextran sulfate, 16 ml of the probe, and 4 ml of salmon sperm DNA (ENZO)
for 24 hr at 377 in a moist chamber (47, 48). The final concentration of the probe in the hybridization solution was 5–10 mg/ml. Prior to hybridization,
the probe was boiled for 4 min and immediately chilled on ice. The grids were then washed at room temperature once in formamide/41 SSC (1/
1 v/v) for 10 min, twice in 41 SSC for 5 min, twice in 0.21 SSC for 5 min, and once in distilled water for 5 min (49). Indirect detection of digitonin
was performed by incubation with rabbit anti-digitonin polyclonal antibodies (Serotec AHP 235) in PBS containing 0.1% bovine serum albumin (BSA)
for 1 hr, followed by goat anti-rabbit polyclonal IgG (Amersham) conjugated with 10-nm gold particles (50). Grids with sections were counterstained
with uranyl acetate and lead citrate. As a control, some samples were treated with 1 mg/ml RNase A (BDH Biochemicals) in 10 mM Tris–HCl (pH
7.3) for 1 hr at 377 prior to hybridization. Nu, nucleolus. Bar, 0.2 mm.
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FIG. 3. In the presence of Rev gag mRNA accumulates over the nuclear membrane. The gag mRNA was visualized as in Fig. 2 using digitonin-
labeled riboprobe (A) or biotin-labeled DNA probe (B–F). Bar, 0.2 mm. NM, nuclear membrane; PM, plasma membrane.
vicinity or across the nuclear membrane. The actin (Fig. tein with the RRE-containing gag mRNA, we visualized
Rev protein in cells cotransfected with pB37R and the rev6) and GAPDH mRNAs appeared to be randomly distrib-
uted in the nucleus and the cytoplasm. expression plasmid pLsrev, using an anti-Rev antibody
followed by immunogold staining. Rev protein was ob-To explore the possibility of colocalizing the Rev pro-
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FIG. 4. Examples of long nucleoplasmic track-like patterns of gag mRNA in the presence of Rev. The RNA was detected as in Fig. 2 using
biotinylated DNA probe. Bar, 0.2 mm. Nu, nucleolus.
AID VY 8398 / 6a28$$8398 01-21-97 13:07:50 viras AP: Virology
367SHORT COMMUNICATION
FIG. 5. Localization of Rev protein by immunogold electron microscopy in HLtat cells transfected with pB37R and pLsrev. Cells were fixed and
embedded in LR White as described above for in situ hybridization. After blocking in PBS containing 1% BSA, the sections were incubated for 1 hr
with rabbit polyclonal anti-HIV-1 Rev antiserum (23) in PBS containing 1% BSA. After several washes in PBS containing 1% BSA and 0.2% Tween
20, the sections were incubated with goat anti-rabbit IgG conjugated with 10-nm colloidal gold particles in PBS containing 1% BSA and 0.2% Tween
20. A representative region around the nucleolus is shown. Bar, 0.2 mm. Nu, nucleolus; NM, nuclear membrane.
AID VY 8398 / 6a28$$8398
01-21-97 13:07:50 viras AP: Virology
368 SHORT COMMUNICATION
FIG. 6. Localization of b-actin mRNA in HLtat cells by in situ hybridization and electron microscopy. The probes for human b-actin and GAPDH
mRNAs (data not shown) were prepared by PCR amplification of the respective cDNAs as described in (51) and labeled with biotin as described
above. The b-actin probe was complementary to the junction of exons 5 and 6 (positions 2655–2955 of human b-actin gene, GenBank Accession
No. M10277). The GAPDH probe spanned the junction of exons 3 and 4 of the respective gene (positions 3121–3400, GenBank Accession No.
J040380). Visualization of cellular mRNAs was performed as described for Fig. 2, in the same samples and under the same conditions that were
used for the analysis of gag mRNA. Bar, 0.2 mm.
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served mostly in the nucleoli (Fig. 5), while less Rev can longer track-like gag mRNA patterns in the nucleoplasm
remains less clear. Since they are Rev-induced, they arebe found in the nucleoplasm. From the indirect immuno-
fluorescence and light microscopy data it is known that likely to result from posttranscriptional regulation of gag
mRNA. However, they were not observed to cross theRev predominantly accumulates in the nucleolus (16, 30,
31). A similar picture has been obtained for the EM local- nuclear membrane and therefore cannot be unambigu-
ously interpreted as trafficking patterns.ization of the bovine immunodeficiency virus Rev protein
(32). We did not detect Rev protein at the NM, the site In summary, the data presented here provide direct
evidence of nonrandom localization of an mRNA in re-where specific patterns of gag mRNA were located.
Since the nucleolus is thought to be a storage site of sponse to posttranscriptional regulation specific to this
mRNA. Taken together with other ultrastructural studiesRev protein rather than a location relevant to its nucleocy-
toplasmic transport function, only a small fraction of Rev on specific mRNA localization, our results imply that, as
a consequence of Rev regulation, a subset of gag mRNAsmolecules may be involved in mRNA trafficking which
may not be detected with the technique used herein. can be detected in transit across the nuclear membrane.
These data further support the suggested role of RevIn this study, we found that in the presence of the
posttranscriptional activator Rev, the RRE-containing gag protein in the transport of RRE-containing mRNAs and
provide direct visualization of such transport.mRNA frequently formed nonrandom track-like nuclear
patterns. By fluorescence immunohistochemistry some
viral and endogenous mRNAs have been observed in ACKNOWLEDGMENTS
nuclear foci or tracks (reviewed in 52). Such nonrandom V.R. and A.Z. contributed equally to this work. Research sponsored
patterns are believed to result from: (i) nascent mRNA at in part by the National Cancer Institute, DHHS, under contract with
ABL. We thank Drs. G. N. Pavlakis, E. I. Afonina, J. Maizel, and P. Lemkinthe site of transcription, (ii) stalling of pre-mRNA at the
for discussions, J. Bear and J. Harrison for technical assistance, J.sites of splicing, (iii) a physical mRNA trail associated
Dobbs for p24gag antigen capture assays, and A. Arthur for editing.with nuclear export, or (iv) combinations of the above.
In this study, we used a well-defined system of mRNA
REFERENCESregulation by Rev protein of HIV-1 to look at the differen-
1. Cochrane, A., Chen, C.-H., and Rosen, C. A., Proc. Natl. Acad. Sci.tial effect of Rev on the Rev-dependent mRNA. We ex-
USA 87, 1198–1202 (1990).pected this effect to be posttranscriptional, since Rev is
2. Daefler, S., Klotman, M. E., and Wong-Staal, F., Proc. Natl. Acad.
known to act only at this level. Accordingly, in this study, Sci. USA 87, 4571–4575 (1990).
only a small (1.5-fold) effect of Rev was found on the net 3. Daly, T. J., Cook, K. S., Gray, G. S., Maione, T. E., and Rusche, J. R.,
Nature 342, 816–819 (1989).nucleoplasmic labeling and the labeling of the entire cell.
4. Heaphy, S., Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Karn,Furthermore, the posttranscriptional effect of Rev is likely
J., Lowe, A. D., Singh, M., and Skinner, M. A., Cell 60, 685–693to reflect its mRNA transport function, since the gag
(1990).
mRNA we used does not undergo splicing and does not 5. Holland, S. M., Ahmad, N., Maitra, R. K., Wingfield, P., and Ven-
contain known splice sites. Therefore, it is plausible that katesan, S., J. Virol. 64, 5966–5975 (1990).
6. Malim, M. H., Tiley, L. S., McCarn, D. F., Rusche, J. R., Hauber, J.,the short tracks that we observed over nuclear mem-
and Cullen, B. R., Cell 60, 675–683 (1990).brane result from Rev-induced mRNA trafficking and may
7. Olsen, H. S., Nelbock, P., Cochrane, A. W., and Rosen, C. A., Sci-represent mRNA in transit across the nuclear membrane.
ence 247, 845–848 (1990).
The patterns we observed are similar to these formed 8. Olsen, H. S., Cochrane, A. W., Dillon, P. J., Nalin, C. M., and Rosen,
by Balbiani ring ribonucleoprotein particles translocating C. A., Genes Dev. 4, 1357–1364 (1990).
9. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G., and Hasel-through the nuclear membranes detected at the EM level
tine, W. A., Proc. Natl. Acad. Sci. USA 85, 2071–2075 (1988).(33, 34). Likewise, recent EM studies of human cytomeg-
10. Zapp, M., and Green, M., Nature (London) 342, 714–716 (1989).alovirus immediate early mRNA localization revealed
11. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanasso-
similar nonrandom labeling on the nuclear membrane poulos, A., Tse, A., and Pavlakis, G. N., J. Virol. 63, 1265–1274
which strongly implied nucleocytoplasmic mRNA translo- (1989).
12. Arrigo, S. J., and Chen, I. S. Y., Genes Dev. 5, 808–819 (1991).cation (35, 36).
13. D’Agostino, D. M., Felber, B. K., Harrison, J. E., and Pavlakis, G. N.,The putative trafficking patterns of gag mRNA appear
Mol. Cell. Biol. 12, 1375–1386 (1992).to be specific for the Rev-mediated export pathway, since
14. Emerman, M., Vazeux, R., and Peden, K., Cell 57, 1155–1165 (1989).
constitutively expressed cellular mRNAs for b-actin and 15. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., and Wong-
GAPDH were not found to form such patterns. In agree- Staal, F., Cell 46, 807–817 (1986).
16. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland,ment with other studies (37), this may further indicate
T., and Pavlakis, G. N., Proc. Natl. Acad. Sci. USA 86, 1495–that Rev accesses a pathway that is distinct from the
1499 (1989).route used by cellular mRNAs. We hypothesize that trans-
17. Hammarskjo¨ld, M. L., Heimer, J., Hammarskjo¨ld, B., Sangwan, I.,
location of actin and GAPDH mRNAs through the nuclear Albert, L., and Rekosh, D., J. Virol. 63, 1959–1966 (1989).
membrane may be less rate-limiting and therefore more 18. Lawrence, J. B., Cochrane, A. W., Johnson, C. V., Perkins, A., and
Rosen, C. A., New Biol. 3, 1220–1232 (1991).difficult to detect than that of gag mRNA. The nature of the
AID VY 8398 / 6a28$$$762 01-21-97 13:07:50 viras AP: Virology
370 SHORT COMMUNICATION
19. Schwartz, S., Felber, B. K., and Pavlakis, G. N., J. Virol. 66, 150–159 35. Dirks, R. W., Daniel, K. C., and Raap, A. K., J. Cell. Sci. 108, 2565–
2572 (1995).(1992).
36. Macville, M. V. E., Wiesmeijer, K. C., Fransen, J. A. M., Dirks, R. W.,20. Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., and Cullen, B. R.,
and Raap, A. K., Eur. J. Cell Biol. 68, 470–474 (1995).Nature (London) 338, 254–257 (1989).
37. Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W., and Luhrmann,21. Arrigo, S., Heaphy, S., and Haines, J., J. Virol. 66, 5569 –5575
R., Cell 82, 475–483 (1995).(1992).
38. Solomin, L., Felber, B. K., and Pavlakis, G. N., J. Virol. 64, 6010–22. Pavlakis, G. N., Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras,
6017 (1990).C., Athanassopoulos, A., and Drysdale, C. M., in ‘‘Human Retrovi-
39. Tabernero, C., Zolotukhin, A. S., Valentin, A., Pavlakis, G. N., andruses’’ (J. Groopman, I. S. Y. Chen, M. Essex, and R. E. Weiss,
Felber, B. K., J. Virol. 70, 5998–6011 (1996).
Eds.), pp. 141–152. A. R. Liss, New York, 1990.
40. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo¨, E. M., and Pavlakis,
23. D’Agostino, D. M., Ciminale, V., Pavlakis, G. P., and Chieco-Bianchi, G. N., J. Virol. 64, 2519–2529 (1990).
L., AIDS Res. Hum. Retroviruses 11, 1063–1072 (1995). 41. Felber, B., Paskalis, H., Kleinman-Ewing, C., Wong-Staal, F., and
24. Richard, N., Iacampo, S., and Cochrane, A., Virology 204, 123–131 Pavlakis, G., Science 229, 675–679 (1985).
(1994). 42. Graham, F. J., and Van der Eb, A. J., Virology 52, 456–460 (1973).
25. Kalland, K. H., Szilvay, A. M., Langhoff, E., and Haukenes, G., J. Virol. 43. Mermer, B., Felber, B. K., Campbell, M., and Pavlakis, G. N., Nucleic
68, 1475–1485 (1994). Acids Res. 18, 2037–2044 (1990).
26. Kalland, K. H., Szilvay, A. M., Brokstad, K. A., Sætrevik, W., and 44. de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., and Subra-
mani, S., Mol. Cell. Biol. 7, 725–737 (1987).Haukenes, G., Mol. Cell. Biol. 14, 7436–7444 (1994).
45. Newman, G. R., and Jasani, B., Med. Lab. Sci. 41, 238–245 (1984).27. Meyer, B. E., and Malim, M. H., Genes Dev. 8, 1538–1547 (1994).
46. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rab-28. Szilvay, A. M., Brokstad, K. A., Kopperud, R., Haukenes, G., and
son, A., and Martin, M. A., J. Virol. 59, 284–291 (1986).Kalland, K.-H., J. Virol. 69, 3315–3323 (1995).
47. Puvion-Dutilleul, F., Bachellerie, J. P., Visa, N., and Puvion, E., J.29. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K.,
Cell Sci. 107, 1457–1468 (1994).and Pavlakis, G. N., J. Virol. 66, 7176–7182 (1992).
48. Visa, N., Puvion-Dutilleul, F., Harper, F., Bachellerie, J. P., and Puv-
30. Cochrane, A. W., Perkins, A., and Rosen, C. A., J. Virol. 64, 881–
ion, E., Exp. Cell Res. 208, 19–34 (1993).
885 (1990).
49. Escaig-Haye, F., Grigoriev, V., Peranzi, G., Lestienne, P., and Four-
31. Cullen, B. R., Hauber, J., Campbell, K., Sodroski, J. G., Haseltine, nier, J. G., J. Cell Sci. 100, 851–862 (1991).
W. A., and Rosen, C. A., J. Virol. 62, 2498–2501 (1988). 50. Puvion-Dutilleul, F., Bachellerie, J. P., and Puvion, E., Chromosoma
32. Oberste, M. S., Williamson, J. C., Greenwood, J. D., Nagashima, K., 100, 395–409 (1991).
Copeland, T. D., and Gonda, M. A., J. Virol. 67, 6395–6405 (1993). 51. Neumann, M., Saltarelli, M., Harrison, J., Hadziyannis, E., Felber,
33. Mehlin, H., Daneholt, B., and Skoglund, U., Cell 69, 605–613 (1992). B. K., and Pavlakis, G. N., AIDS Res. Hum. Retroviruses 10,
34. Visa, N., Alzhanova-Ericsson, A. T., Sun, X., Kiseleva, E., Bjorkroth, 1527–1538 (1994).
52. Rosbash and Singer, Cell 75, 399–401.B., Wurtz, T., and Daneholt, B., Cell 84, 253–264 (1996).
AID VY 8398 / 6a28$$$763 01-21-97 13:07:50 viras AP: Virology
